Increased serum levels of basic fibroblast growth factor in lung cancer patients: Relevance to response of therapy and prognosis

Lung Cancer

Volumn 31, Issue 2-3, 2001, Pages 213-219

  Ueno, Kiyonobu ^a,b   Inoue, Yoshikazu ^a   Kawaguchi, Tomoya ^a   Hosoe, Shigeto ^a   Kawahara, Masaaki ^a  

^a NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Basic fibroblast growth factor; Lung cancer; Prognosis; Response; Small cell lung cancer

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; CARBOPLATIN; CISPLATIN; VINDESINE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CASE-CONTROL STUDIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0035144946     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(00)00187-2     Document Type: Article

References (32)

1. Clinical applications of research on angiogenesis
2. Angiogenesis in cancer, vascular, rheumatoid and other disease
3. Tumour angiogenesis
4. What is the evidence that tumors are angiogenesis dependent?
5. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma
6. Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas
7. Demonstration and characterization of the angiogenic properties of cervical dysplasia
8. Association of vascular growth factor expression with intratumor microvessel density and tumour cell proliferation in human epidermoid lung carcinoma
9. Relation of neovascularisation to metastasis of non-small cell cancer
10. Tumor angiogenesis in pulmonary adenocarcinomas: relationship with basic fibroblastic growth factor, its receptor, and survival
11. Immunocytochemical markers in stage I lung cancer: relevance to prognosis
12. The FGF family of growth factors and oncogenes
13. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage
14. Serum evaluation of basic fibroblast growth factor in cervical cancer patients
15. Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma
16. Increased serum levels of basic fibroblast growth factor (bFGF) are associated with progressive lung metastases in advanced renal cell carcinoma patients
17. Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders
18. Serum levels of VEGF and basic FGF in the subacute phase of myocardial infarction
19. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients
20. Elevated levels of angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers
21. Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcoma
22. The basic fibroblast growth factor and its receptor in pulmonary adenocarcinomas: an investigation of their expression as prognostic markers
23. Single-agent chemotherapy trails in small-cell lung cancer, 1970 to 1990: the case studies in previously treated patients
24. Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, phamacokinetics, and tumor growth factor expression
25. Principles of cancer management: radiation therapy
26. Fibroblast growth factor 2 in breast cancer: occurrence and prognostic significance
27. Basic fibroblast growth factor causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory G1 events
28. Prognostic factors for survival in advanced non-small cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1052 patients
29. Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small cell lung carcinomas
30. Pilot evaluation of cytokine levels in patients undergoing radiotherapy for brain tumor
31. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients
32. Serum evaluation of basic FGF in breast cancer patients